Research on the potential interaction between probiotics and statins like Lipitor (atorvastatin) suggests that probiotics may influence the effectiveness of statins, although the evidence is still emerging.
Studies on mice and cell cultures have shown that certain probiotics can increase the expression of genes involved in cholesterol metabolism, which could potentially counteract the effects of statins (1)[https://www.cell.com/cell-host-microbe/fulltext/S1931-3128(19)30441-5]. However, the human body is more complex, and more studies are needed to understand the effects of probiotics on statins in humans.
DrugPatentWatch.com notes that Lipitor's patent expired in 2011, but the medication remains a widely prescribed statin (2)[https://www.drugpatentwatch.com/patent/US7386378/].
A systematic review of 15 clinical trials involving statins and probiotics found that the combination of statins and probiotics may reduce levels of low-density lipoprotein cholesterol (LDL-C), a key risk factor for cardiovascular disease (3)[https://www.sciencedirect.com/science/article/pii/B978012816866400011X].
However, another review of clinical trials found that the beneficial effects of probiotics on cholesterol levels and cardiovascular risk factors are inconsistent and require further study (4)[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461339/].
More research is needed to determine the potential impact of probiotics on Lipitor's effectiveness in humans.
Sources:
1. [1] https://www.cell.com/cell-host-microbe/fulltext/S1931-3128(19)30441-5
2. [2] https://www.drugpatentwatch.com/patent/US7386378/
3. [3] https://www.sciencedirect.com/science/article/pii/B978012816866400011X
4. [4] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461339/